Skip to main content
SpringerLink
Log in

Tobacco

  • Chapter
Book cover Substance Abuse

Abstract

Tobacco use, a human-created epidemic, kills one third of the people who use it. Across the world, smoking is the most common form of tobacco use. In several countries, both smoking as well as smokeless tobacco is used among all age groups. In 2002, 50 % of the people killed from tobacco use were from developing countries. In the next two decades, unless urgent action is taken, the number might double and 70 % of deaths are likely be from developing countries. Tobacco-related deaths will be more than eight million in 2030 which is more than the total number of deaths from malaria, maternal and major childhood conditions, and tuberculosis combined.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Murthy P, Mohan B, Hiremath S. Helping people quit tobacco: a manual for doctors and dentists. New Delhi: WHO, Regional Office South East Asia; 2010.

    Google Scholar 

  2. U.S. Department of Health and Human Services. Preventing tobacco use among youth and young adults: a report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2012.

    Google Scholar 

  3. U.S. Department of Health and Human Services. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010.

    Google Scholar 

  4. U.S. Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General—executive summary. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006.

    Google Scholar 

  5. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–27.

    Article  CAS  PubMed  Google Scholar 

  6. Shrivastava RK. Training manual for doctors: National Tobacco Control Programme. New Delhi: DGHS, Ministry of Health and Family Welfare; 2011.

    Google Scholar 

  7. Mackay J, Eriksen M. The tobacco atlas. Geneva: World Health Organization; 2002.

    Google Scholar 

  8. Rigotti NA. Strategies to help a smoker who is struggling to quit. JAMA. 2012;308(15):1573–80.

    Article  CAS  PubMed  Google Scholar 

  9. World Health Organization. WHO Framework Convention on Tobacco Control. Geneva: World Health Organization; 2003.

    Google Scholar 

  10. Pine-Abata H, McNeill A, Raw M, Bitton A, Rigotti N, Murray R. A survey of tobacco dependence treatment guidelines in 121 countries. Addiction. 2013;108:1470–5.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Rajkumar S, Kaur J, Murthy P, Deshpande S, Shah N, Munish VG. Tobacco dependence treatment guidelines. New Delhi: DGHS. Ministry of Health and Family welfare, Government of India; 2011.

    Google Scholar 

  12. Fiore M, Jaen C, Baker T, Bailey WC, Benowitz NL, Curry SJ. Treating tobacco use and dependence: 2008 update. Rockville: US Department of Health and Human Services; 2008.

    Google Scholar 

  13. Miller WR, Rollnick S. Motivational interviewing: preparing people to change addictive behaviours. 2nd ed. New York: Guildford; 2002.

    Google Scholar 

  14. Shiffman S, Kassel J, Gwaltney C, McChargue D. Relapse prevention for smoking. New York: Guilford; 2005.

    Google Scholar 

  15. Himelhoch S, Daumit G. To whom do psychiatrists offer smoking-cessation counseling? Am J Psychiatry. 2003;160(12):2228–30.

    Article  PubMed  Google Scholar 

  16. Boyle RG, Enstad C, Asche SE, et al. A randomized controlled trial of Telephone Counseling with smokeless tobacco users: the ChewFree Minnesota study. Nicotine Tob Res. 2008;10(9):1433–40.

    Article  PubMed  Google Scholar 

  17. Murthy P, Subodh BN. Current developments in behavioral interventions for tobacco cessation. Curr Opin Psychiatry. 2010;23(2):151–6.

    Article  PubMed  Google Scholar 

  18. Tzelepis F, Paul CL, Walsh RA, McElduff P, Knight J. Proactive telephone counseling for smoking cessation: meta-analyses by recruitment channel and methodological quality. J Natl Cancer Inst. 2011;103(12):922–41.

    Article  PubMed  Google Scholar 

  19. Civljak M, Sheikh A, Stead LF, Car J. Internet-based interventions for smoking cessation. Cochrane Database Syst Rev. 2010;(9):CD007078.

    Google Scholar 

  20. Varghese C, Kaur J, Desai NG, et al. Initiating tobacco cessation services in India: challenges and opportunities. WHO South-East Asia J Public Health. 2012;1(2):159–68.

    Google Scholar 

  21. Molyneux A. Nicotine replacement therapy. BMJ. 2004;328(7437):454–6.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Crane R. The most addictive drug, the most deadly substance: smoking cessation tactics for the busy clinician. Prim Care. 2007;34(1):117–35.

    Article  PubMed  Google Scholar 

  23. Grief SN. Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy. Prim Care. 2011;38(1):23–39, v.

    Article  PubMed  Google Scholar 

  24. Hays JT, McFadden DD, Ebbert JO. Pharmacologic agents for tobacco dependence treatment: 2011 update. Curr Atheroscler Rep. 2012;14(1):85–92.

    Article  CAS  PubMed  Google Scholar 

  25. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012:(11):CD000146. doi:10.1002/14651858.CD000146.pub4.

  26. Bailey AM, Macaulay T. Pharmacologic approaches to smoking cessation. Orthopedics. 2012;35(6):505–11.

    Article  PubMed  Google Scholar 

  27. Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ. 2009;338:b1024.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Lingford-Hughes AR, Welch S, Peters L, Nutt DJ. BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. J Psychopharmacol. 2012;26(7):899–952.

    Article  CAS  PubMed  Google Scholar 

  29. Schnoll RA, Patterson F, Wileyto EP, et al. Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Ann Intern Med. 2010;152(3):144–51.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Mills EJ, Wu P, Lockhart I, Wilson K, Ebbert JO. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tob Induc Dis. 2010;8:8.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Smith SS, McCarthy DE, Japuntich SJ, et al. Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. Arch Intern Med. 2009;169(22):2148–55.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Piper ME, Smith SS, Schlam TR, et al. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry. 2009;66(11):1253–62.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2007;(1):CD000031.

    Google Scholar 

  34. Mooney ME, Sofuoglu M. Bupropion for the treatment of nicotine withdrawal and craving. Expert Rev Neurother. 2006;6(7):965–81.

    Article  CAS  PubMed  Google Scholar 

  35. Mills EJ, Wu P, Lockhart I, Thorlund K, Puhan M, Ebbert JO. Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis. Ann Med. 2012;44(6):588–97.

    Article  CAS  PubMed  Google Scholar 

  36. Schnoll RA, Martinez E, Tatum KL, et al. A bupropion smoking cessation clinical trial for cancer patients. Cancer Causes Control. 2010;21(6):811–20.

    Article  PubMed  Google Scholar 

  37. Evins AE, Culhane MA, Alpert JE, et al. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. J Clin Psychopharmacol. 2008;28(6):660–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Beyens MN, Guy C, Mounier G, Laporte S, Ollagnier M. Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004. Drug Saf. 2008;31(11):1017–26.

    Article  CAS  PubMed  Google Scholar 

  39. Thase ME, Haight BR, Johnson MC, et al. A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension. J Clin Psychopharmacol. 2008;28(3):302–7.

    Article  CAS  PubMed  Google Scholar 

  40. West R, Zatonski W, Cedzynska M, et al. Placebo-controlled trial of cytisine for smoking cessation. N Engl J Med. 2011;365(13):1193–200.

    Article  CAS  PubMed  Google Scholar 

  41. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2012;(4):CD006103. doi:10.1002/14651858.CD006103.pub6.

  42. Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation. 2010;121(2):221–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Tashkin DP, Rennard S, Hays JT, Ma W, Lawrence D, Lee TC. Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. Chest. 2011;139(3):591–9.

    Article  PubMed  Google Scholar 

  44. Singh S, Loke YK, Spangler JG, Furberg CD. Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. CMAJ. 2011;183(12):1359–66.

    Article  PubMed Central  PubMed  Google Scholar 

  45. Gunnell D, Irvine D, Wise L, Davies C, Martin RM. Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. BMJ. 2009;339:b3805.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Tonstad S, Davies S, Flammer M, Russ C, Hughes J. Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis. Drug Saf. 2010;33(4):289–301.

    Article  CAS  PubMed  Google Scholar 

  47. Gibbons RD, Mann JJ. Varenicline, smoking cessation, and neuropsychiatric adverse events. Am J Psychiatry. 2013. doi:10.1176/appi.ajp.2013.12121599.

    PubMed Central  Google Scholar 

  48. Etter JF. Cytisine for smoking cessation: a literature review and a meta-analysis. Arch Intern Med. 2006;166(15):1553–9.

    Article  CAS  PubMed  Google Scholar 

  49. Gourlay SG, Stead LF, Benowitz NL. Clonidine for smoking cessation. Cochrane Database Syst Rev. 2004;(3):CD000058.

    Google Scholar 

  50. Herman AI, Sofuoglu M. Comparison of available treatments for tobacco addiction. Curr Psychiatry Rep. 2010;12(5):433–40.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Drug De-Addiction and Treatment Center, Chandigarh, India

    Debasish Basu M.D., Ph.D.

  2. Department of Anesthesia and Intensive Care, Government Medical College and Hospital, Chandigarh, India

    Sukanya Mitra M.D., Ph.D.

  3. Department of Anesthesiology, Yale University, New Haven, CT, USA

    Nalini Vadivelu M.D.

Authors
  1. Debasish Basu M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sukanya Mitra M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nalini Vadivelu M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Debasish Basu M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Louisiana State University Health Sciences Center, Louisiana State University Interim Hospital, and Ochsner Kenner Hospital, Departments of Anesthesiology and Pharmacology, New Orleans, Louisiana, USA

    Alan David Kaye

  2. Department of Anesthesiology, Yale University School of Medicine and Yale-New Haven Hospital, New Haven, Connecticut, USA

    Nalini Vadivelu

  3. Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA

    Richard D. Urman

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Basu, D., Mitra, S., Vadivelu, N. (2015). Tobacco. In: Kaye, A., Vadivelu, N., Urman, R. (eds) Substance Abuse. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1951-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1951-2_9

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1950-5

  • Online ISBN: 978-1-4939-1951-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation